196PHGCSG1403: Phase I trial of oxaliplatin/irinotecan/S-1 (OX-IRIS) as first-line chemotherapy for unresectable pancreatic cancer. (25th November 2018)

Record Type:: Journal Article
Title:: 196PHGCSG1403: Phase I trial of oxaliplatin/irinotecan/S-1 (OX-IRIS) as first-line chemotherapy for unresectable pancreatic cancer. (25th November 2018)
Main Title:: 196PHGCSG1403: Phase I trial of oxaliplatin/irinotecan/S-1 (OX-IRIS) as first-line chemotherapy for unresectable pancreatic cancer
Authors:: Yoshikawa, A
Kawamoto, Y
Yuki, S
Nakano, S
Sawada, K
Muranaka, T
Nakatsumi, H
Harada, K
Kobayashi, Y
Miyagishima, T
Saiki, T
Ishiguro, A
Saito, R
Ehira, N
Iwanaga, I
Hatanaka, K
Abe, N
Sakamoto, N
Sakata, Y
Komatsu, Y
Abstract:
Is Part Of:: Annals of oncology. Volume 29(2018)Supplement 9
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 9
Issue Display:: Volume 29, Issue 9 (2018)
Year:: 2018
Volume:: 29
Issue:: 9
Issue Sort Value:: 2018-0029-0009-0000
Page Start:
Page End:
Publication Date:: 2018-11-25
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdy432.048 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12251.xml